Regulation 19A Decision to allow use of vaccinesF1
(1)
The Department may decide to allow the use of inactivated or live attenuated vaccines against bluetongue provided that—
(a)
such decision is based on the result of a specific risk assessment; and
(b)
the EU Commission is informed of that decision before the vaccination is carried out.
(2)
When live attenuated vaccines are used, the Department must declare—
(a)
a protection zone consisting of at least the vaccination area; and
(b)
a surveillance zone extending beyond the limit of the protection zone.
Annotations
Textual amendments
- F1
Reg. 19A inserted (19.11.2012) by The Bluetongue (Amendment) Regulations (Northern Ireland) 2012 (S.R. 2012/383), regs. 1, 2(7)